Atrium Therapeutics shares owned by KBC Group NV
Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by KBC Group NV
from 13F filings
Historical chart of KBC Group NV investment in Atrium Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Atrium Therapeutics held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Atrium Therapeutics by KBC Group NV
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $5.0k | 337 | 14.84 |